Active-ingredient Dossier
Methadone Hydrochloride
Active-ingredient Dossier for Methadone Hydrochloride (opioid agonist). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: METHADONE-AFT
- Brand: PHYSEPTONE
- Brand: BIODONE
- Brand: Methadone
- Brand: OPOD-
- Therapeutic area: Pain Management
- Therapeutic area: Psychiatry
What is
Methadone Hydrochloride Methadone Hydrochloride is an opioid agonist.
Australian brands containing
Methadone Hydrochloride — METHADONE-AFT — PHYSEPTONE — BIODONE
Therapeutic areas
Methadone Hydrochloride is registered in Oncology (4 brands) and Pain & Anaesthesia (1 brand).
Sponsor landscape
The ingredient is marketed by four sponsors: Aspen Pharmacare, Biomed Aust, Phebra, and AFT Pharmaceuticals.
PBS and regulatory activity
Two brands containing Methadone Hydrochloride have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is 1 July 2025, with one brand having a PBAC outcome recorded.